| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6246384 | Transplantation Proceedings | 2016 | 5 Pages |
Abstract
Anti-HLA antibody as detected by Luminex PRA was associated with early allograft rejection but not graft or patient survival. The effect of newer treatment modalities can improve the outcomes of PRA-positive patients to be similar to nonsensitized patients at 1 year.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
P. Wiwattanathum, A. Ingsathit, D. Thammanichanond, T. Mongkolsuk, V. Sumethkul,